Dynamics of humoral and cellular response to three doses of the anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects
We are thrilled to announce the publication of our latest research: “Dynamics of humoral and cellular response to three doses of the anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects.” While the risk of Sars-CoV-2 infection has decreased, it remains a concern for vulnerable populations, particularly patients with hematological malignancies and older […]